FMR LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$1,912,000
-98.8%
79,997
-99.3%
0.00%
-100.0%
Q4 2020$157,076,000
+3.8%
10,758,659
+0.9%
0.01%
-6.7%
Q3 2020$151,382,000
-1.5%
10,660,698
+2.0%
0.02%
-11.8%
Q2 2020$153,738,000
+309.3%
10,451,263
+14.6%
0.02%
+240.0%
Q1 2020$37,559,000
-10.3%
9,116,380
+4.7%
0.01%0.0%
Q4 2019$41,890,000
-19.8%
8,709,057
+1.1%
0.01%
-16.7%
Q3 2019$52,213,000
-6.0%
8,615,899
+0.7%
0.01%0.0%
Q2 2019$55,517,000
-7.6%
8,554,282
+1.0%
0.01%
-14.3%
Q1 2019$60,058,000
+47.2%
8,470,863
+0.9%
0.01%
+16.7%
Q4 2018$40,791,000
-33.6%
8,393,292
+0.4%
0.01%
-14.3%
Q3 2018$61,468,000
+15.9%
8,362,958
+0.6%
0.01%
+16.7%
Q2 2018$53,030,000
+17.8%
8,311,860
+0.5%
0.01%
+20.0%
Q1 2018$45,014,000
+31.3%
8,274,612
+0.7%
0.01%
+25.0%
Q4 2017$34,274,000
-56.6%
8,219,259
+0.2%
0.00%
-60.0%
Q3 2017$78,967,000
-16.8%
8,200,112
+2.2%
0.01%
-16.7%
Q2 2017$94,883,000
+4.9%
8,020,502
+13.6%
0.01%
+9.1%
Q1 2017$90,480,000
+6.2%
7,057,680
+1.4%
0.01%0.0%
Q4 2016$85,198,000
+12.0%
6,960,646
+7.9%
0.01%
+10.0%
Q3 2016$76,099,000
+36.3%
6,449,083
+0.5%
0.01%
+25.0%
Q2 2016$55,838,000
+65.2%
6,418,138
+0.1%
0.01%
+60.0%
Q1 2016$33,798,000
-31.6%
6,413,321
+0.7%
0.01%
-28.6%
Q4 2015$49,401,000
-1.3%
6,366,108
+0.1%
0.01%0.0%
Q3 2015$50,033,000
-12.6%
6,357,379
+0.6%
0.01%0.0%
Q2 2015$57,252,000
-29.8%
6,319,217
+0.6%
0.01%
-30.0%
Q1 2015$81,544,000
-4.3%
6,282,297
+0.4%
0.01%
-9.1%
Q4 2014$85,201,000
+51.7%
6,260,145
+0.0%
0.01%
+37.5%
Q3 2014$56,146,000
-34.0%
6,259,255
-0.4%
0.01%
-27.3%
Q2 2014$85,049,000
+36.1%
6,285,9550.0%0.01%
+22.2%
Q1 2014$62,482,000
-24.6%
6,285,955
+1.0%
0.01%
-25.0%
Q4 2013$82,821,000
+12.6%
6,222,439
+2.8%
0.01%
+9.1%
Q3 2013$73,551,000
+44.7%
6,053,558
+23.2%
0.01%
+37.5%
Q2 2013$50,827,0004,915,5580.01%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders